GKB Ophthalmics Ltd. has issued a notice pursuant to Regulation 29 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors meeting is scheduled for Wednesday, August 12, 2026, at the company's Registered Office at 16-A, Tivim Industrial Estate, Mapusa, Goa 403 526. The primary agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (Q1 FY27).
The notice of the meeting is available on the company's website at www.gkb.net.
Regarding insider trading compliance, the Trading Window for dealing in the company's equity shares by designated persons under the SEBI (Prohibition of Insider Trading) Regulations, 2015, had been closed from July 1, 2026. The window will reopen after 48 hours from the date of submission of the financial results to the Stock Exchange.
This communication has been sent to all Directors and all designated employees of the company. The letter is signed by Pooja Dessai, Company Secretary, from the Registered Office.
#GKB Ophthalmics #BoardMeeting #SEBILODR #Reg29 #Reg47 #FinancialResults #TradingWindowClosure